Nathan Shapiro, MD (Emergency Medicine, BIDMC) discusses a clinical trial to test a repurposed antiviral AIDS drug for at-home treatment during the first days of COVID-19 symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death.

A new research is hoping to nip a COVID-19 infection in the bud before it progresses. (WJAR)

Sharon Wright, MD (Infectious Disease, BIDMC) discusses recently announced directives that have been put in place to help slow the spread of COVID-19 cases in Massachusetts.

Beth Israel doctor on Mass. new COVID-19 directives

As of Oct. 27, the investigational vaccine developed as part of a partnership between Johnson & Johnson and a team led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) is one of 11 COVID-19 vaccines currently in Phase 3 efficacy trials. At least 88 preclinical vaccines are under active investigation in animals, with another 48 in early human trials.

How Much Will It Cost To Get the Coronavirus Vaccine?

Marsha Maurer, DPN, RN, (CNO, BIDMC) discusses the gradual increase of hospitalizations due to COVID-19 infections and how the hospital is preparing.

While daily case counts above 1,000 across the state are concerning, Beth Israel's chief nursing officer said that the increase in hospitalizations has been more gradual this time around

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the process of mass-producing vaccines.

Moderna: 'We're Ready' To Ship 20 Million Coronavirus Vaccine Doses By The End Of 2020

Nathan Shapiro, MD, (Emergency Medicine, BIDMC) discusses a clinical trial to test a repurposed antiviral AIDS drug for at-home treatment during the first days of COVID-19 symptoms in hopes of slowing the virus early and heading off hospitalization, intensive care, and death.

Trial begins of at-home treatment that may keep early cases from growing severe

Nathan Shapiro, MD, (Emergency Medicine, BIDMC) discusses restaurants and the COVID-19 pandemic. Shapiro was one of the authors of a CDC study released in September that found that people who tested positive for COVID-19 were approximately twice as likely to have reported dining at a restaurant than those who tested negative.

Dining out is one of the riskiest things you can do—but it doesn’t have to be, if you follow these steps.

Katheryn Stephenson, MD, MPH discusses the timeline for COVID-19 vaccine clinical trials

Some Americans concerned about possible ...

Satchit Balsari, MD (Emergency Medicine, BIDMC) discusses how mobility data could be used to fight COVID-19, and notes that the region is on the move again compared to the beginning of the pandemic.

WCVB – October 26, 2020